Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Objective: To estimate the prevalence of amyotrophic lateral sclerosis (ALS) in the United States for 2016 using data from the National ALS Registry (Registry). Established in 2009, the Registry collects data on ALS patients in the U.S. to better describe the epidemiology of ALS, examine risk factors such as environmental and occupational exposures, and characterize the demographics of those living with the disease. Methods: To identify adult prevalent cases of ALS, the Registry compiles data from three national administrative databases (maintained by the Centers for Medicare and Medicaid Services, the Veterans Health Administration, and the Veterans Benefits Administration). To ascertain cases not necessarily included in these databases and to better understand risk-factors associated with ALS and disease progression, the Registry also includes data collected from patients who voluntarily enroll via a web portal to complete online surveys. Results: In 2016, the Registry conservatively identified 16,424 adult persons who met the Registry definition of ALS for an age-adjusted prevalence rate of 5.2 per 100,000 U.S. population. The pattern of patient characteristics (e.g., age, sex, and race/ethnicity) has not changed from previous Registry reports. Overall, ALS was more common among whites, males, and persons aged 60–69 years. The age groups with the lowest number of ALS cases were persons aged 18–39 years. Males had a higher prevalence rate of ALS than females overall and across all data sources. Conclusions: Data collected by the National ALS Registry are being used to better describe the epidemiology and demographics of ALS in the U.S.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As the resource from the Centers for Disease Control and Prevention (CDC) in the United States, the ALS prevalence rate was the lowest among individuals aged 18–39, with only 0.2 cases per 100,000 people. In contrast, the prevalence rate was highest in the 70–79 year age group, reaching 17.2 cases per 100,000 people.24”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Massachusetts Department of Public Health
Gallagher, S. S., Guyer, B., Kotelchuck, M., Bass, J., Lovejoy, F. H., McLoughlin, E., & Mehta, K. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071613 · Cited by 591
Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014
Mehta, P., Kaye, W., Raymond, J., Wu, R., Larson, T., Punjani, R., Heller, D., Cohen, J., Peters, T., Muravov, O., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6707a3 · Cited by 458
Self-citationEstimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015.
Mi, M., Atkins, C. Y., Santibanez, S. S., Knust, B., Petersen, B. W., Ervin, E., Nichol, S. T., Damon, I. K., & Washington, M. L. (2014) · PubMed · Cited by 348
Onset, natural history and outcome in idiopathic adult motor neuron disease
Norris, F., Shepherd, R., Denys, E., U, K., Mukai, E., Elias, L., Holden, D., & Norris, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90245-t · Cited by 302
Incidence and prevalence of ALS in Ireland, 1995–1997: A population-based study
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. (1999) · Neurology · doi:10.1212/wnl.52.3.504 · Cited by 292
The accuracy of medicare claims data in identifying Alzheimer's disease
Taylor, D. H., Fillenbaum, G. G., & Ezell, M. E. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00452-3 · Cited by 258
Prospective study of military service and mortality from ALS
Weisskopf, M. G., O’Reilly, E. J., McCullough, M. L., Calle, E. E., Thun, M. J., Cudkowicz, M., & Ascherio, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148649.17706.d9 · Cited by 197
Wittes, J. T., Colton, T., & Sidel, V. W. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90005-8 · Cited by 186 · cited 1×
“Capture-recapture is a statistical method that estimates the number of missing cases from different data sources (31,32).”
MethodThe Value of Capture-Recapture Methods Even for Apparent Exhaustive Surveys
Hook, E. B., & Regal, R. R. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116400 · Cited by 174
Research works printed but not linked: 6
- US Public Health Service, 2008, ALS Registry Act
- Mehta P, 2014, MMWR Suppl, 63, 1
- Klein RJ, 2001, Healthy People 2010 Stat Notes., 1
- Keyfitz N., 1966, Hum Biol, 38, 309
- Huber S, 1995, Schweiz Arch Neurol Psychiatr (1985), 146, 52
- US Census Bureau, 2014, Total population 2014 American community survey 1-year
Cited by
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Xu, L., Liu, T., Liu, L., Yao, X., Chen, L., Fan, D., Zhan, S., & Wang, S. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09652-y · Cited by 318
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
Holland, D., Frei, O., Desikan, R., Fan, C.-C., Shadrin, A. A., Smeland, O. B., Sundar, V. S., Thompson, P., Andreassen, O. A., & Dale, A. M. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1008612 · Cited by 237
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Metadata
- Authors
- Mehta, P., Raymond, J., Punjani, R., Larson, T., Bove, F., Kaye, W., Nelson, L. M., Topol, B., Han, M., Muravov, O., Genson, C., Davis, B., Hicks, T., & Horton, K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA
- McKing Consulting (United States) (US)
- Stanford Medicine (US)
- Carter Consulting, Inc, Atlanta, GA, USA
- Corresponding author
- Mehta, Paul
- Venue
- Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Publisher
- Informa UK Limited
- Published
- 2021-08-23
- Volume
- 23
- Issue
- 3-4
- Pages
- 220-225
- ISSN
- 2167-8421 (ISSN-L)
- 2167-9223
- OpenAlex
- W3194791349
- Cited by
- 84
- References
- 53
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 10 · 2021: 14
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/mark/1.0/ (vor)
- Locations
- Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- amyotrophic lateral sclerosis, prevalence, National ALS Registry, sex differences, age distribution, racial and ethnic differences, risk factors, disease progression, United States
- MeSH terms
- Adult, Aged, Amyotrophic Lateral Sclerosis, Female, Medicare, Humans, Male, Registries, United States, Prevalence, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. https://app.cochat.ai/papers/10.1080/21678421.2021.1949021
- The paper
- Mehta, P., Raymond, J., Punjani, R., Larson, T., Bove, F., Kaye, W., Nelson, L. M., Topol, B., Han, M., Muravov, O., Genson, C., Davis, B., Hicks, T., & Horton, K. (2022). Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. https://doi.org/10.1080/21678421.2021.1949021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.